MetaCap

LifeMD (LFMD) vs P3 Health Partners (PIII)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

LifeMD (LFMD) has outperformed P3 Health Partners (PIII) over the past year, losing 62.5% versus a loss of 70.4%. Over five years, LFMD leads with a -65.9% price change compared with -99.7% for PIII. P3 Health Partners is the larger company by market cap ($350.2 million vs $69.8 million), about 5.0 times the size, while LifeMD is growing revenue faster (+25.3% vs -2.8%).

LifeMD converts more of its revenue into profit, with a net margin of 7.4% versus -10.1%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

LFMD-62.47%PIII-70.40%
+202%+58%-86%
Nov 21, 20251 yearNov 20, 2026
LFMD-68.17%PIII-99.66%
+241%+63%-116%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

LFMD versus PIII key metrics
MetricLFMDPIII
Share price$1.45$1.69
Market cap$69.84M$350.24M
1-day change-9.40%-9.14%
YTD return-57.62%-51.58%
1-year return-62.47%-70.40%
5-year return-65.92%-99.66%
Forward P/E9.32—
EPS (TTM)$-0.52$-23.21
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$194.06M$1.46B
Revenue growth (YoY)+25.34%-2.76%
Net income (latest FY)$14.35M$-147.95M
Gross margin85.72%—
Operating margin-3.95%-18.53%
Net margin7.40%-10.14%
52-week high$5.38$16.89
52-week low$1.38$1.52
Distance from 52-week high-73.14%-89.99%
Analyst consensusstrong_buybuy
Avg. price target upside+462.63%+358.58%
Average volume929.40K30.85K
Shares outstanding48.33M4.02M
Employees347320
SectorHealth CareHealth Care
IndustryMedical/Nursing ServicesMedical/Nursing Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • P3 Health Partners is about 5.0 times larger than LifeMD by market value ($350.24M vs $69.84M).
  • LifeMD is more profitable, keeping 7.4 cents of every revenue dollar as net income versus -10.1 cents for P3 Health Partners.
  • LifeMD grew revenue faster in its latest fiscal year (+25.34% vs -2.76%).

About LifeMD

LFMD stock →

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States.

Health Care · Medical/Nursing Services · 347 employees

About P3 Health Partners

PIII stock →

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers.

Health Care · Medical/Nursing Services · 320 employees

LFMD vs PIII FAQ

Which is bigger, LifeMD or P3 Health Partners?

P3 Health Partners (PIII) is larger, with a market capitalization of $350.24M compared with $69.84M for LifeMD (LFMD).

Which stock has performed better over the past year, LFMD or PIII?

LFMD returned -62.47% over the past 12 months, compared with -70.40% for PIII (price return, excluding dividends). Past performance does not predict future results.

Are LifeMD and P3 Health Partners in the same industry?

Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.

More comparisons